Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126003611 | 12600361 | 1 | I | 20140718 | 20160720 | 20160727 | 20160727 | EXP | US-SA-2016SA136091 | AVENTIS | 0.00 | A | M | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126003611 | 12600361 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | UNKNOWN | 20839 | ||||||||||
126003611 | 12600361 | 2 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | UNKNOWN | 20839 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126003611 | 12600361 | 1 | Thrombosis prophylaxis |
126003611 | 12600361 | 2 | Cardiac disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126003611 | 12600361 | HO |
126003611 | 12600361 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126003611 | 12600361 | Death | |
126003611 | 12600361 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126003611 | 12600361 | 1 | 20100219 | 0 | ||
126003611 | 12600361 | 2 | 20100219 | 0 |